Healthy volunteers needed to test safety of experimental drug GR2303
NCT ID NCT07199270
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study is testing a new drug, GR2303, in 64 healthy adults to see if it is safe and how the body handles it. Participants will receive either the drug or a placebo and be monitored for side effects. This study does not aim to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH ADULT SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Friendship hospital, Capital Medical University
RECRUITINGBeijing, Beijing Municipality, 100050, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can the right work-rest rhythm and a massage gun soften stiff calf muscles?
- Beetroot boost: does more nitrate mean more endurance?
- What makes people move? new study probes the secrets of physical activity
- New daily pill TIX100 takes first step toward tackling obesity
- New skin ointment takes first step toward treating inflammatory conditions
- One yoga session may boost heart health overnight